Holdings of F/m Emerald Life Sciences Innovation ETF
ISIN US74933W2219
RBB Fund, Inc. · Original filing · Compare with another fund · Report an error
- Net assets
- 105.1M $ including 105.1M $ in equities, 100.0 %
- Positions
- 39 in 2 countries
- Top ten
- 54.7 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TRAVERE THERAPEUTICS INC | 170,714 | 8.1M $ | 7.67 % |
| 2 | COGENT BIOSCIENCES INC | 226,142 | 7.9M $ | 7.53 % |
| 3 | LivaNova PLC | 101,212 | 7.5M $ | 7.11 % |
| 4 | Spyre Therapeutics Inc | 91,588 | 6.7M $ | 6.41 % |
| 5 | GUARDANT HEALTH INC | 44,694 | 5.8M $ | 5.52 % |
| 6 | MIRUM PHARMACEUTICALS INC | 50,911 | 5.2M $ | 4.92 % |
| 7 | Corcept Therapeutics Inc | 72,454 | 5M $ | 4.79 % |
| 8 | United Therapeutics Corp | 7,841 | 4.4M $ | 4.16 % |
| 9 | VERADERMICS INC | 35,568 | 3.6M $ | 3.42 % |
| 10 | SAVARA INC | 651,024 | 3.4M $ | 3.22 % |
| 11 | CYTOKINETICS INC | 43,268 | 3.3M $ | 3.16 % |
| 12 | Nektar Therapeutics | 50,876 | 3.3M $ | 3.14 % |
| 13 | Trevi Therapeutics Inc | 231,602 | 3.3M $ | 3.12 % |
| 14 | Dianthus Therapeutics Inc | 34,884 | 3.2M $ | 3.09 % |
| 15 | Axsome Therapeutics Inc | 12,723 | 3M $ | 2.84 % |
| 16 | Billiontoone Inc | 29,023 | 2.9M $ | 2.73 % |
| 17 | TRANSMEDICS GROUP INC | 41,894 | 2.8M $ | 2.68 % |
| 18 | VIRIDIAN THERAPEUTICS INC | 133,261 | 2.3M $ | 2.24 % |
| 19 | ICU Medical Inc | 16,227 | 2.2M $ | 2.09 % |
| 20 | Corvus Pharmaceuticals Inc | 165,305 | 2.1M $ | 1.95 % |
| 21 | PALVELLA THERAPEUTICS INC | 17,254 | 2M $ | 1.95 % |
| 22 | Ceribell Inc | 88,354 | 1.6M $ | 1.55 % |
| 23 | Globus Medical Inc | 16,258 | 1.3M $ | 1.27 % |
| 24 | Xeris Biopharma Holdings Inc | 207,543 | 1.3M $ | 1.22 % |
| 25 | Bridgebio Pharma Inc | 18,534 | 1.2M $ | 1.17 % |
| 26 | Integer Holdings Corp | 13,436 | 1.2M $ | 1.14 % |
| 27 | TWIST BIOSCIENCE CORP | 17,850 | 1.2M $ | 1.14 % |
| 28 | F/m Ultrashort Treasury Inflat | 22,751 | 1.1M $ | 1.08 % |
| 29 | WAYSTAR HOLDING CORP | 55,155 | 1.1M $ | 1.05 % |
| 30 | WAVE LIFE SCIENCES LTD | 152,008 | 1M $ | 0.95 % |
| 31 | Hinge Health Inc | 17,590 | 988.7K $ | 0.94 % |
| 32 | Korro Bio Inc | 62,855 | 842.9K $ | 0.80 % |
| 33 | RadNet Inc | 14,899 | 827.3K $ | 0.79 % |
| 34 | Aveanna Healthcare Holdings Inc | 105,779 | 758.4K $ | 0.72 % |
| 35 | Lumexa Imaging Holdings Inc | 94,977 | 738.9K $ | 0.70 % |
| 36 | Insmed Inc | 6,050 | 646.8K $ | 0.62 % |
| 37 | Alphatec Holdings Inc | 77,386 | 599.7K $ | 0.57 % |
| 38 | NeoGenomics Inc | 43,071 | 453.1K $ | 0.43 % |
| 39 | Alamar Biosciences Inc | 9,442 | 193K $ | 0.18 % |
Sector breakdown
- Health care 4.8 %
- Unattributed 95.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 99.0 %
- Singapore 1.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 38 | 104.1M $ | 99.05 % |
| 2 | Singapore | 1 | 1M $ | 0.95 % |
Cite this page
Titelia. "Holdings of F/m Emerald Life Sciences Innovation ETF". https://titelia.com/en/funds/S000088167